As a primary metabolic organ in the human body, the liver plays a key role in the regulation of lipid metabolism and is sensitive to energy intake. Hepatic steatosis is an early pathological condition of the liver and can lead to steatohepatitis, cirrhosis, liver failure and severe cardiovascular diseases.
Accumulating evidence indicates that hepatic steatosis is a low-grade inflammatory response and commonly occurs in individuals with insulin resistance and obesity. In the liver, the impaired insulin signalling pathway, which involves the insulin receptor substrate (IRS) proteins and AKT cascade, results in insulin insensitivity and glucose intolerance. This impairment in insulin signalling, together with inflammatory response, promotes hepatic lipid synthesis and steatosis, which in turn contribute to chronic hepatic inflammation and insulin resistance.
Thus, insulin resistance, inflammatory response and hepatic steatosis are interconnected pathological events that are often observed in obese individuals. Although extensive research has been conducted in this area, the complex interlinked molecular events and related cellular behaviors that occur during the initiation and progression of hepatic steatosis are not fully understood.
The tumor necrosis factor receptor (TNFR)-associated factor (TRAF) family consists of seven members (TRAF1–TRAF7) that can function as signalling adaptors in various pathophysiologic processes. Among TRAF members, TRAF3 was first identified as a protein interacting with CD40 cytoplasmic domain and is ubiquitously expressed.
Previous studies indicated that TRAF3-regulated molecular events and cellular responses are largely cell type- and stress-dependent. Considering the close implication of NF-κB/JNK in insulin function and inflammatory response that intimately associated with fatty acid metabolism in hepatocytes, authors hypothesize that TRAF3 might be involved in the pathogenesis of hepatic steatosis.
They generated hepatocyte-specific TRAF3-KO and TRAF3-transgenic mice and subjected to them to a high-fat diet (HFD) to evaluate the effects of TRAF3 on hepatic steatosis and related metabolic disorder. After 24 weeks on a high-fat diet (HFD), obesity, insulin resistance, hepatic steatosis and inflammatory responses are significantly ameliorated in liver-specific TRAF3-knockout mice, but exacerbated in transgenic mice overexpressing TRAF3 in hepatocytes.
The detrimental effects of TRAF3 on hepatic steatosis and related pathologies are confirmed in ob/ob mice. Authors further show that in response to HFD, hepatocyte TRAF3 binds to TGF-β-activated kinase 1 (TAK1) to induce TAK1 ubiquitination and subsequent auto-phosphorylation, thereby enhancing the activation of downstream NF-κB and MKK–JNK– signalling cascades, while disrupting AKT–GSK3β/FOXO1 signalling.
The TRAF3–TAK1 interaction and TAK1 ubiquitination are indispensable for TRAF3-regulated hepatic steatosis. In conclusion, hepatocyte TRAF3 promotes HFD-induced or genetic hepatic steatosis in a TAK1-dependent manner.
http://www.nature.com/ncomms/2016/160217/ncomms10592/full/ncomms10592.html
Signaling mechanism in non-alcoholic fatty liver disease
- 6,117 views
- Added
Edited
Latest News
Protein that helps COVID-19…
By newseditor
Posted 26 Jul
Spinal Muscular Atrophy (SM…
By newseditor
Posted 26 Jul
Link between bowel movement…
By newseditor
Posted 26 Jul
Inhibition of IL-11 signall…
By newseditor
Posted 25 Jul
Brain changes linked to obe…
By newseditor
Posted 25 Jul
Other Top Stories
Selective promiscuity in the binding of E. coli Hsp70 to an unfolde…
Read more
Spaceflight wreaks havoc on liver metabolism
Read more
How hyaluronic acid shape the organs
Read more
How do our organs know when to stop growing?
Read more
New mechanism for protecting DNA identified!
Read more
Protocols
A systems biology approach…
By newseditor
Posted 24 Jul
quantms: a cloud-based pipe…
By newseditor
Posted 22 Jul
Emerging tools and best pra…
By newseditor
Posted 19 Jul
Directly selecting cell-typ…
By newseditor
Posted 17 Jul
PUFFFIN: an ultra-bright, c…
By newseditor
Posted 16 Jul
Publications
Hepatocyte-intrinsic SMN de…
By newseditor
Posted 26 Jul
Aberrant bowel movement fre…
By newseditor
Posted 26 Jul
A pseudoautosomal glycosyla…
By newseditor
Posted 26 Jul
Microglia protect against a…
By newseditor
Posted 26 Jul
Rigor and reproducibility i…
By newseditor
Posted 26 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar